Diligence memo · auto-generated · as of July 2, 2026
Shunwang International Institute of Medicine & Food Homology Research Ltd
Shunwang International Institute of Medicine & Food Homology Research Ltd looks fair against its niche peers and is active on financing cadence.
Businessfiled
Shunwang International Institute of Medicine & Food Homology Research Ltd operates in Agtech / Foodtech, based in HONG KONG.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Shunwang International Institute of Medicine & Food Homology Research Ltd has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2025-11-24.
Most recent recorded round closed around 2025-11-24.
Valuation (modeled)modeled
Provath models Shunwang International Institute of Medicine & Food Homology Research Ltd at approximately $14M (range $6.4M–$21M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.92× the median modeled value of Series A Agtech / Foodtech companies in 2025–2027 (12 peers) — value vs value, same stage and era. Within the normal band (92% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 7 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 67% of Agtech / Foodtech peers (481 compared).
Modeled value ranks above 62% of those peers.
Closest niche peers: Gruns Nutrition, Inc., Above Food Ingredients Inc., Laoban Foods Inc., Barfresh Food Group Inc., 4P Foods, Inc. PBC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.